BioCryst Pharmaceuticals Inc
XMUN:BO1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BioCryst Pharmaceuticals Inc
XMUN:BO1
|
US |
|
Amaroq Minerals Ltd
F:72Q
|
CA |
|
D
|
DigiPlus Interactive Corp
XPHS:PLUS
|
PH |
|
E
|
Energous Corp
F:116
|
US |
|
Ausgold Ltd
F:AU4
|
AU |
|
CleanSpark Inc
F:3UX
|
US |
|
Evolv Technologies Holdings Inc
NASDAQ:EVLV
|
US |
|
Weebit Nano Ltd
F:6RI
|
AU |
|
P
|
Precious Shipping PCL
SET:PSL
|
TH |
|
Cash Converters International Ltd
F:UKC
|
AU |
|
P
|
Public Power Corporation SA
F:PU8
|
GR |
|
E
|
Enphase Energy Inc
F:E0P
|
US |
|
MMTC Ltd
BSE:513377
|
IN |
|
T
|
Telenor ASA
XMUN:TEQ
|
NO |
|
I
|
Ivanhoe Mines Ltd
F:IYAA
|
CA |
|
H
|
Huaneng Power International Inc
OTC:HUNGF
|
CN |
Bankruptcy Probability
BioCryst Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
BioCryst Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
|
2.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
398.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
186.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
155.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
BioCryst Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, BioCryst Pharmaceuticals Inc has total debt of 803.6m USD. This includes both short-term (0 USD) and long-term (803.6m USD) debt.
You can find a full breakdown on its Balance Sheet.
